SUMMARY Haemostatic variables were measured in 61 patients with heterozygous familial hypercholesterolaemia, 32 of whom had evidence of coronary heart disease. Age adjusted mean concentrations of plasma fibrinogen and factor VIII were significantly higher in these patients than in the 29 patients without coronary heart disease, but there were no significant differences in serum lipid concentrations between the two groups. Comparisons in 30 patients taking and not taking lipid lowering drugs showed lower values for low density lipoprotein cholesterol, high density lipoprotein cholesterol and antithrombin III, and a higher high density lipoprotein ratio while receiving treatment. The results suggest that hypercoagulability may play a role in the pathogenesis of coronary heart disease in patients with familial hypercholesterolaemia.
Premature coronary disease is a characteristic feature of heterozygous familial hypercholesterolaemia and up to 50% of male and 25% of female patients with familial hypercholesterolaemia develop symptoms of coronary ischaemia by the age of 50. 1 2 Increased concentrations of low density lipoprotein (LDL) play a major role in the pathogenesis of this premature atherosclerosis, but accelerated intravascular coagulation3 and increased plasma fibrinogen concentrations have also been reported.4 5 Preliminary results from the Northwick Park heart study have shown an association between high plasma concentrations of factor VII, factor VIII, and fibrinogen and an increased risk of subsequent cardiovascular death. 6 We have therefore measured these and other haemostatic variables in patients with familial hypercholesterolaemia with or without overt coronary heart disease and in addition have studied the effects of hypolipidaemic drugs on these variables.
Patients and methods
Sixty one patients (34 men, 27 women) aged 20- Accepted for publication 23 October 1984 cholesterolaemia were studied. FamiLial hypercholesterolaemia was defined as serum cholesterol concentration >7 5 mmol/l in an adult or >6 7 mmol/l in children under the age of 16, together with tendon xanthomata or with hypercholesterolaemia plus tendon xanthomata or hypercholesterolaemia plus premature coronary disease (before the age of 60) in a first degree relative. Tendon xanthomata were present in 57% of patients. Most patients had a type IIa phenotype, but seven had raised serum triglyceride concentrations (>2 mmol/1) and a type Ilb phenotype. All patients were receiving a low cholesterol diet, four had had a partial ileal bypass, and 44 were taking hypolipidaemic drugs (cholestyramine 17, probucol 8, clofibrate 6, neomycin 1, cholestyramine and clofibrate 6, cholestyramine and neomycin 6). The presence of significant coronary disease was defined on the basis of one or more of the following: a reduction of : 50% in the luminal diameter of any major coronary artery when seen in two projections at coronary arteriography which was performed where there was a clinical indication; the presence of angina or a positive 16 lead exercise precordial map7; and electrocardiographic evidence of previous myocardial infarction. 8 Coronary arteriograms were reviewed by two observers and assigned a score designed to (5); coronary arteriographic abnormalities without infarct (6) ; coronary arteriographic abnormalities and infarct (10) ; and angina or a positive exercise precordial map or both (11) . Seven patients had had previous coronary artery bypass surgery. The 29 patients without coronary disease, of whom 17 were men and 12 women, were younger than those with coronary disease (mean age 38-4, range 20-59 years).
There were no significant differences in any lipid variables between the two groups but mean concentrations offibrinogen and factor VIII were significantly higher in the patients with coronary disease than in those without (Table 1) . To see whether either of these differences could be accounted for by associations between factor VIII or fibrinogen and lipids, values for cholesterol, triglycerides, and HDL were included in further regression analyses as explanatory variables. The results did not differ materially from those shown in Table 1 .
Untreated patients and those in whom hypolipidaemic drugs had been temporarily withdrawn had significantly higher LDL and HDL cholesterol concentrations and a lower HDL ratio compared with the treated state. Antithrombin III was significantly higher in patients not receiving treatment (90% vs 82/o, p<002), but none of the other haemostatic variables showed any significant difference (Table 2) . Table 3 shows the effects of individual drug regimens. The small number of patients in each group precludes detailed statistical analysis, but the decrease in antithrombin III concentrations appeared to be greatest in patients taking probucol.
Coronary arteriograms were performed in 16 patients (13 men, three women, mean age 44 years). Angiographic scores ranged from 1 to 9. The correlation between angiographic score and factor VIII was -0-27 (p=0.33) and for fibrinogen -0.10 (p=073).
Discussion
Premature and angiographically severe coronary dis- (13) +9 (7) -9 (14) Factor VII (9(s)
+2 (40) -6 (20) +22 (22) +10 (13) +4 (18) Factor VIII (%) [25] [26] [27] Nevertheless, the slight but significant decrease in the thrombin inhibitor antithrombin III observed in our patients with familial hypercholesterolaemia while taking lipid lowering drugs is potentially adverse; this effect was most pronounced in patients taking probucol or cholestyramine in combination with neomycin, in whom a theoretically undesirable decrease in HDL cholesterol was also observed. Probucol and neomycin are each known to reduce both LDL and HDL,28 29 but the decrease in HDL cholesterol was not seen in patients taking cholestyramine alone. The major effect of lipid lowering treatment overall was to decrease LDL cholesterol by 18%, which resulted in a significant increase in the HDL ratio. Comparable changes in a similar group of patients with hypercholesterolaemia treated with diet and cholestyramine for five years were recently shown to be associated with a reduction in the rate of progression of their coronary disease on angiography.303' DDS was supported by a grant from CORDA. 
